OTC : CLPBY

Coloplast A/S

$6.7 USD

-$0.06 (-0.89%)

Volume
39K
Average Volume
464.31K
Market Capitalization
$15.1B
P/E Ratio
45.97
Dividend Yield
5.36%
Price Target
$14.45
Year High
$10.03
Year Low
$5.64
Day High
—
Day Low
—
Payout Ratio
$2.46
Current Ratio
$1.75
Company Overview

OTC

Gavin Wood

Medical - Instruments & Supplies

Healthcare

CLPBY

17083

DK

USD

https://www.coloplast.com

45 49 11 11 11

19624Y200

0001294325

Liquidity Metrics

1.89

1.75

1.09

0.18

2.46

Sales & Valuation

$26.25B

3.45

7.54

16.04

2.68

Profitability

$1.52

$3.42B

7.51%

12.28%

14.23%

4.51%

P/E Metrics

45.97

-0.86

-0.86

Analyst Price Target & Rating

$14.45

$14.45

$14.45

Sell

2/5

8 Analysts

-53.63%

Financial Health Scores

3.36

6/9

$4.48B

$46.7B

$33.84B

$7.35B

Key Metrics (TTM)

$119.91B

4.28

10.56

1.75

14.23%

10.58%

2.18%

6.24%

$109.46

146 days

Company Executives
Name Title
Anders Lonning-Skovgaard Executive Vice President & Chief Financial Officer
Alain Morvan Senior Vice President of Sales Europe
Gavin Wood President & Chief Executive Officer
Nicolai Buhl Andersen Executive Vice President of Chronic Care
Thomas Barfod Senior Controller & Employees Representative Director
Dennis Kaysen Vice President of Corporate Communications
Caroline Vagner Rosenstand Executive Vice President of Chronic Care Commercial
Allan Rasmussen Executive Vice President of Global Operations
Aleksandra Dimovska Vice President of Investor Relations
Mads Mikkelsen VP of People & Culture - Chronic Care Commercial and Interim Head of Global People & Culture
Poll Results

No votes yet today — be the first to share your view!

About Coloplast A/S (OTC:CLPBY) Stock

Coloplast A/S, founded in 1954 and headquartered in Humlebæk, Denmark, operates as a global developer and marketer of intimate healthcare products and services. Its extensive reach spans Denmark, the United States, the United Kingdom, France, and numerous other international regions. The company's activities are organized into three primary segments: Chronic Care, Interventional Urology, and Wound & Skin Care. Within Chronic Care, Coloplast provides advanced ostomy solutions, including the SenSura Mio, recognized for its adaptable fit and discretion, alongside other SenSura offerings and Brava brand accessories. This segment also delivers continence care products such as Conveen Active urine bags, SpeediCath catheters for diverse users, and the Peristeen transanal irrigation system. The Wo ... und & Skin Care division features innovative dressings like the conforming Biatain Silicone and the hydrocolloid Comfeel. Additionally, it offers a broad spectrum of skin care items, encompassing bathing and cleansing products, moisturizers, skin protectants, antifungal treatments, hand cleansers, odor control solutions, and the specialized InterDry system for managing skin folds. Finally, the Interventional Urology segment is dedicated to crafting and commercializing surgical devices that address a range of urological and gynecological conditions, such as urinary stone disease, benign prostatic hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence.

Coloplast: Went 'BUY' A Bit Early

2026-05-16 10:37:53

Coloplast is rebased to a 20x P/E with a new price target of 490 DKK, reflecting a more realistic valuation post-premiumization. Recent setbacks—the Kerecis acquisition write-down, product recalls, and regulatory shifts—have driven shares down, but core fundamentals and inelastic product demand remain intact. CLPBY now trades at a historically low sub-18x P/E, offering a 5.76% yield and potential 12–13% annualized growth until 2028E, supporting a buy rating.

Coloplast A/S (CLPBY) Q2 2026 Earnings Call Transcript

2026-05-12 12:10:51

Coloplast A/S (CLPBY) Q2 2026 Earnings Call Transcript

Frequently Asked Questions

What is the current Coloplast A/S (CLPBY) stock price?

Coloplast A/S(OTC:CLPBY) stock price is $6.7 in the last trading session. During the trading session, CLPBY stock reached the peak price of $10.03 while $5.64 was the lowest point it dropped to. The percentage change in CLPBY stock occurred in the recent session was --0.89% while the dollar amount for the price change in CLPBY stock was -$0.06.

CLPBY's industry and sector of operation?

The OTC listed CLPBY is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.

Who are the executives of CLPBY?

Anders Lonning-Skovgaard | Executive Vice President & Chief Financial Officer
Alain Morvan | Senior Vice President of Sales Europe
Gavin Wood | President & Chief Executive Officer
Nicolai Buhl Andersen | Executive Vice President of Chronic Care
Thomas Barfod | Senior Controller & Employees Representative Director

How many employees does CLPBY have?

Number of CLPBY employees currently stands at 17083. CLPBY operates from Holtedam 1-3, Humlebæk, ZE 3050, DK.

Link for CLPBY official website?

Official Website of CLPBY is: https://www.coloplast.com

How do I contact CLPBY?

CLPBY could be contacted at phone #45 49 11 11 11 and can also be accessed through its website. CLPBY operates from Holtedam 1-3, Humlebæk, ZE 3050, DK.

How many shares of CLPBY are traded daily?

The average number of CLPBY shares traded daily for last 3 months was 464.31K.

What is the market cap of CLPBY currently?

The market value of CLPBY currently stands at $15.1B with its latest stock price at $6.7